Indonesia's Halodoc closes drug delivery unit as COVID bites

Telemedicine startup ties up with insurers to get corporate deals

20210401 halodoc

Halodoc CEO and co-founder Jonathan Sudharta said the company closed its drug delivery unit as orders fell during the pandemic. (Photo by Yuki Kohara) 

CINDY SILVIANA, DealStreetAsia

JAKARTA -- Halodoc, an Indonesian health-tech platform, was forced to shut down one of its business units that had been hit by the COVID-19 pandemic, a top company executive told DealStreetAsia.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.